Litcius/Paper detail

Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records

Yan Xie, Benjamin Bowe, Hong Xian, Travis Loux, Janet B. McGill, Ziyad Al‐Aly

2023The Lancet Diabetes & Endocrinology92 citationsDOI

Topics & Concepts

MedicineMetforminAdverse effectPharmacologyPlaceboMaceInternal medicineClinical trialAlternative medicineInsulinMyocardial infarctionConventional PCIPathologyDiabetes Treatment and ManagementHeart Failure Treatment and ManagementMedication Adherence and Compliance
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records | Litcius